Literature DB >> 23684608

RhoGAPs attenuate cell proliferation by direct interaction with p53 tetramerization domain.

Jie Xu1, Xiaolin Zhou, Jilin Wang, Zhaoli Li, Xuan Kong, Jin Qian, Ye Hu, Jing-Yuan Fang.   

Abstract

Many Rho GTPase activation proteins (RhoGAPs) are deleted or downregulated in cancers, but the functional consequences are still unclear. Here, we show that the RhoGAP ArhGAP11A induces cell-cycle arrest and apoptosis by binding to the tumor suppressor p53. The RhoGAP domain of ArhGAP11A binds to the tetramerization domain of p53, but not to its family members p63 or p73. The interaction stabilizes the tetrameric conformation of p53 and enhances its DNA-binding activity, thereby inducing cell-cycle arrest and apoptosis. Upon DNA damage stress, ArhGAP11A accumulates in the nucleus and interacts with p53, whereas knockdown of ArhGAP11A partially blocks p53 transcriptional activity. These findings explain why RhoGAPs are frequently deleted in cancers and suggest that the RhoGAP family sits at the crossroads between the cell-migration and proliferation pathways.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23684608     DOI: 10.1016/j.celrep.2013.04.017

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  24 in total

1.  PIWI-interacting RNA 021285 is involved in breast tumorigenesis possibly by remodeling the cancer epigenome.

Authors:  Alan Fu; Daniel I Jacobs; Aaron E Hoffman; Tongzhang Zheng; Yong Zhu
Journal:  Carcinogenesis       Date:  2015-07-25       Impact factor: 4.944

Review 2.  Rho, nuclear actin, and actin-binding proteins in the regulation of transcription and gene expression.

Authors:  Eeva Kaisa Rajakylä; Maria K Vartiainen
Journal:  Small GTPases       Date:  2014-03-06

3.  Inhibitory effects of Arhgap6 on cervical carcinoma cells.

Authors:  Junping Li; Yang Liu; Yihua Yin
Journal:  Tumour Biol       Date:  2015-12-01

Review 4.  Fixing the GAP: The role of RhoGAPs in cancer.

Authors:  Gabriel Kreider-Letterman; Nicole M Carr; Rafael Garcia-Mata
Journal:  Eur J Cell Biol       Date:  2022-02-10       Impact factor: 6.020

5.  p53 oligomerization status modulates cell fate decisions between growth, arrest and apoptosis.

Authors:  Nicholas W Fischer; Aaron Prodeus; David Malkin; Jean Gariépy
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

Review 6.  Filling GAPs in our knowledge: ARHGAP11A and RACGAP1 act as oncogenes in basal-like breast cancers.

Authors:  Campbell D Lawson; Channing J Der
Journal:  Small GTPases       Date:  2016-09-26

7.  Rho GTPase Transcriptome Analysis Reveals Oncogenic Roles for Rho GTPase-Activating Proteins in Basal-like Breast Cancers.

Authors:  Campbell D Lawson; Cheng Fan; Natalia Mitin; Nicole M Baker; Samuel D George; David M Graham; Charles M Perou; Keith Burridge; Channing J Der; Kent L Rossman
Journal:  Cancer Res       Date:  2016-05-23       Impact factor: 12.701

Review 8.  Scaffold Proteins in Gastrointestinal Tumors as a Shortcut to Oncoprotein Activation.

Authors:  Chushu Li; Huanbin Wang; Han Yao; Jing-Yuan Fang; Jie Xu
Journal:  Gastrointest Tumors       Date:  2017-07-12

9.  Expression and prognostic analysis of Rho GTPase-activating protein 11A in lung adenocarcinoma.

Authors:  Shuchen Chen; He Duan; Yusai Xie; Xiaoling Li; Yuxia Zhao
Journal:  Ann Transl Med       Date:  2021-05

10.  Heterogeneity of Li-Fraumeni syndrome links to unequal gain-of-function effects of p53 mutations.

Authors:  Jie Xu; Jin Qian; Ye Hu; Jilin Wang; Xiaolin Zhou; Haoyan Chen; Jing-Yuan Fang
Journal:  Sci Rep       Date:  2014-02-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.